Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells

Mol Pharmacol. 2000 Nov;58(5):1115-28. doi: 10.1124/mol.58.5.1115.

Abstract

In the present study, the effects on intracellular calcium concentration ([Ca(2+)](i)) oscillations of the blockade of ether-a-go-go-related gene (ERG) K(+) channels and of Ca(2+) influx through store-operated channels (SOC) activated by [Ca(2+)](i) store depletion have been studied in GH(3) cells by means of a combination of single-cell fura-2 microfluorimetry and whole-cell mode of the patch-clamp technique. Nanomolar concentrations (1-30 nM) of the piperidinic second-generation antihistamines terfenadine and astemizole and of the class III antiarrhythmic methanesulfonanilide dofetilide, by blocking ERG K(+) channels, increased the frequency and the amplitude of [Ca(2+)](i) oscillations in resting oscillating GH(3) cells. These compounds also induced the appearance of an oscillatory pattern of [Ca(2+)](i) in a subpopulation of nonoscillating GH(3) cells. The effects of ERG K(+) channel blockade on [Ca(2+)](i) oscillations appeared to be due to the activation of L-type Ca(2+) channels, because they were prevented by 300 nM nimodipine. By contrast, the piperazinic second-generation antihistamine cetirizine (0.01-30 microM), which served as a negative control, failed to affect ERG K(+) channels and did not interfere with [Ca(2+)](i) oscillations in GH(3) cells. Interestingly, micromolar concentrations of terfenadine and astemizole (0.3-30 microM), but not of dofetilide (10-100 microM), produced an inhibition of the spontaneous oscillatory pattern of [Ca(2+)](i) changes. This effect was possibly related to an inhibition of SOC, because these compounds inhibited the increase of [Ca(2+)](i) achieved by extracellular calcium reintroduction after intracellular calcium store depletion with the sarcoplasmic or endoplasmic reticulum calcium ATPase pump inhibitor thapsigargin (10 microM) in an extracellular calcium-free medium. The same inhibitory effect on [Ca(2+)](i) oscillations and SOC was observed with the first-generation antihistamine hydroxyzine (1-30 microM), the more hydrophobic metabolic precursor of cetirizine. Collectively, the results of the present study obtained with compounds that interfere in a different concentration range with ERG K(+) channels or SOC suggest that 1) ERG K(+) channels play a relevant role in controlling the oscillatory pattern of [Ca(2+)](i) in resting GH(3) cells and 2) the inhibition of SOC might induce an opposite effect, i.e., an inhibition of [Ca(2+)](i) oscillations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Astemizole / pharmacology
  • Biological Transport / drug effects
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism
  • Calcium Channels, L-Type / metabolism
  • Cation Transport Proteins*
  • Cells, Cultured
  • Cetirizine / pharmacology
  • Electrophysiology
  • Ether-A-Go-Go Potassium Channels
  • Histamine H1 Antagonists / pharmacology*
  • Hydroxyzine / pharmacology
  • Large-Conductance Calcium-Activated Potassium Channels
  • Nimodipine / pharmacology
  • Phenethylamines / pharmacology
  • Pituitary Gland / cytology
  • Pituitary Gland / drug effects*
  • Pituitary Gland / metabolism
  • Potassium Channel Blockers*
  • Potassium Channels / metabolism
  • Potassium Channels, Calcium-Activated*
  • Potassium Channels, Voltage-Gated*
  • Rats
  • Small-Conductance Calcium-Activated Potassium Channels
  • Sulfonamides / pharmacology
  • Terfenadine / pharmacology

Substances

  • Anti-Arrhythmia Agents
  • Calcium Channel Blockers
  • Calcium Channels
  • Calcium Channels, L-Type
  • Cation Transport Proteins
  • Ether-A-Go-Go Potassium Channels
  • Histamine H1 Antagonists
  • KCNH6 protein, human
  • Kcnh6 protein, rat
  • Large-Conductance Calcium-Activated Potassium Channels
  • Phenethylamines
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Calcium-Activated
  • Potassium Channels, Voltage-Gated
  • Small-Conductance Calcium-Activated Potassium Channels
  • Sulfonamides
  • Hydroxyzine
  • Nimodipine
  • Terfenadine
  • Astemizole
  • dofetilide
  • Calcium
  • Cetirizine

Grants and funding